je.st
news
Tag: eisai
Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC
2015-02-14 13:04:00| Biotech - Topix.net
Eisai Inc. announced today that the U.S. Food and Drug Administration approved the company's receptor tyrosine kinase inhibitor LENVIMA for the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer . LENVIMA was approved following a priority review by the FDA, which is designated for drugs the FDA believes have the potential to provide a significant improvement in the treatment of a serious condition.
Tags: treatment
approval
announces
fda
Eisai opens new packaging facility for cancer-treating compound in UK
2014-11-27 01:00:00| Packaging Gateway
Global R&D-based pharmaceutical company Eisai has opened a new facility for the packaging of its investigational advanced thyroid cancer-treating compound lenvatinib at its EMEA Knowledge Centre in Hatfield, UK.
Tags: uk
facility
opens
packaging
Eisai to Present New Research on Oncology Products and Pipeline at 50th Asco Annual Meeting
2014-05-15 07:54:39| Logistics - Topix.net
Highlights Include New Phase Iii Clinical Data on Investigational Anticancer Agent Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer Tokyo, May 15, 2014 - - Eisai Co., Ltd. announced today that a series of abstracts highlighting new study results on Halaven and lenvatinib with a novel binding mode) will be presented during the 50th ... (more)
Tags: products
research
present
meeting
Eisai And Biogen Idec Enter Collaboration To Develop And Commercialize Alzheimer's Disease Treatments
2014-03-05 05:29:31| drugdiscoveryonline News Articles
Eisai Co., Ltd. and Biogen Idec recently announced that they have entered into a collaboration to develop and commercialize two of Eisai’s clinical candidates for Alzheimer’s disease (AD), E2609 and BAN2401
Tags: enter
develop
disease
collaboration
Eisai to add packaging facility to UK pharma production plant
2013-06-19 01:00:00| Packaging Gateway
Eisai, a Japanese pharmaceutical company, has announced plans to invest 8m to create an additional packaging facility at its production plant in Hatfield, Hertfordshire, UK.
Tags: add
production
plant
facility